Cited by 3Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Network analysis identifies strain-dependent response to tau and tau seeding-associated genes

Open access
Acri, Dominic J., You, Yanwen, Tate, Mason D., Karahan, Hande, Martinez, Pablo, McCord, Brianne, Sharify, A. Daniel, John, Sutha +10 more·2023·Journal of Experimental Medicine

Published version of a preprint

Abstract

Previous research demonstrated that genetic heterogeneity is a critical factor in modeling amyloid accumulation and other Alzheimer’s disease phenotypes. However, it is unknown what mechanisms underlie these effects of genetic background on modeling tau aggregate-driven pathogenicity. In this study, we induced tau aggregation in wild-derived mice by expressing MAPT. To investigate the effect of genetic background on the action of tau aggregates, we performed RNA sequencing with brains of C57BL/6J, CAST/EiJ, PWK/PhJ, and WSB/EiJ mice (n = 64) and determined core transcriptional signature conserved in all genetic backgrounds and signature unique to wild-derived backgrounds. By measuring tau seeding activity using the cortex, we identified 19 key genes associated with tau seeding and amyloid response. Interestingly, microglial pathways were strongly associated with tau seeding activity in CAST/EiJ and PWK/PhJ backgrounds. Collectively, our study demonstrates that mouse genetic context affects tau-mediated alteration of transcriptome and tau seeding. The gene modules associated with tau seeding provide an important resource to better model tauopathy.

AI snapshot

Written from the paper’s full text.

TL;DR

This study expressed AAV-hTauP301L in C57BL/6J and three wild-derived mouse strains to test how genetic background affects tau seeding and cortical transcriptomes. CAST and PWK showed increased tau seeding independent of tau expression, and network analysis implicated a 666-gene microglial/innate-immune module as a putative mediator.

Key findings

  • Tau seeding activity was significantly affected by genetic background (one-way ANOVA: F3,78 = 9.237, P = 2.67 × 10−5), with elevated seeding in CAST and PWK relative to B6 (*P < 0.001; B6-CAST p_adj = 0.046, B6-PWK p_adj = 1.12 × 10−4), but no significant B6 vs WSB difference. This was independent of human tau expression: no genetic-background effect on hMAPT mRNA (F3,66 = 0.234, P = 0.87), total tau (F3,75 = 1.439, P = 0.238), or pTau231 (F3,75 = 1.665, P = 0.189).
  • Bulk RNA-seq identified a core tau-responsive Signature A of 2,467 DEGs shared across all genetic backgrounds, out of total DEGs of 4,784 in B6, 5,260 in CAST, 4,657 in PWK, and 4,958 in WSB. Signature A was enriched for neurodegeneration pathways, including 168 of 471 genes in KEGG map05022 “Pathways of neurodegeneration—multiple diseases.”
  • Signature B comprised 133 DEGs in one or more wild-derived backgrounds, with 17 shared by CAST, PWK, and WSB; there were 53 CAST-specific, 22 PWK-specific, and 25 WSB-specific DEGs. These were not large enough to reach significance in enrichment analyses, but the 133 genes were enriched for pathways such as asthma and Staphylococcus aureus infection.
  • WGCNA identified 60 modules, 21 significantly associated with seeding activity or wild-derived genetic background. The darkorange module (Signature C) contained 666 genes, was positively correlated with FRET seeding (R2 = 0.54, P = 7 × 10−6) and wild-derived background (R2 = 0.27, P = 0.03), and was a significant mediator by HIMA (P = 0.0349), most likely via complete mediation; it was enriched for microglia-related terms, with 21 homeostatic and 18 disease-associated microglial marker genes.

Methods

  • Mice from C57BL/6J, CAST/EiJ, PWK/PhJ, and WSB/EiJ backgrounds received intracerebroventricular AAV9-CBA/CMV-hTauP301L or AAV-eGFP at postnatal day 0 and were harvested at 6 mo; final sample sizes were B6 = 20, CAST = 20, PWK = 19, WSB = 24. Genotyping used the gigaMUGA platform with 143,259 markers, and variants were filtered against AMP-AD nominated target genes.
  • Tau seeding was measured with HEK-293T TauRD P301S FRET biosensor cells transfected with TBS-soluble cortical lysate, with FRET+ signal measured by FACS. Tau expression/pathology was assessed by qPCR, Meso Scale Diagnostics for total tau and pTau231, histology, and Western blotting.
  • Bulk mRNA-seq was performed on cortex (n = 8/background/AAV injection group; 32/AAV group), with DESeq2 for per-strain and interaction-model DEG analyses and WGCNA for co-expression modules. Mediation was tested with HIMA and bmediatR, and targeted validation used the nCounter mouse neuroinflammation panel (n = 3/genotype/injection, females).

Limitations

  • Stated: microglial transcriptional state was inferred from bulk transcriptomic data, and single-cell RNA-seq will be necessary to determine which microglial cell types are involved. Future experiments are needed to test functional effects of candidate genes by knockdown one by one, in combination, and in a cell-type-specific manner.
  • Stated: more research is necessary to understand which tau species contribute to the increased seeding activity in wild-derived cortex. Genotyping was limited to variants captured by the selected Illumina Infinium platform.
  • Stated/evident: WGCNA did not reach the recommended scale-free topology fit cutoff of 0.9, and a soft power threshold of 6 was selected based on package recommendations for datasets with more than 40 samples. The cross-study meta-analysis could not match sex, exact brain region, promoter, or genetic background.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1084/jem.20230180

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Claims the paper makes

44 of 48 cited sources checked · 28 supported · 1 flagged · accuracy not yet measured

  • Premisecitation

    Mice with APPswe and PSEN1de9 transgenes backcrossed onto wild-derived backgrounds had higher levels of amyloid-β compared with age-matched mice on a B6 background.

    “These mice had higher levels of amyloid-β (Aβ) compared with age-matched mice on a B6 background (Onos et al., 2019).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Onos et al., 2019 source

      The Results section, “Evidence of mixed pathologies in wild-derived APP/PS1 strains,” reports higher Aβ42 levels than in B6.APP/PS1 mice for female CAST.APP/PS1 and WSB.APP/PS1 mice at 8 months. It does not establish higher Aβ levels for all wild-derived backgrounds or for males; it also reports fewer cortical plaques in all three wild-derived strains. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
  • Premisecitation

    Responses of homeostatic microglia and disease-associated microglia are determined by wild-derived genetic backgrounds.

    “Single-cell RNA sequencing (RNA-seq) of sorted microglia further demonstrated that the responses of immune cell subtypes, namely homeostatic microglia and disease-associated microglia (DAMs), are determined by wild-derived genetic backgrounds (Yang et al., 2021).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Yang et al., 2021 source
  • Findingown data

    Neurodegenerative hub-genes were detected by comparing Signature C (darkorange) and wild-derived amyloid response (Fisher's exact test: P = 1.62 × 10−19).

    “Neurodegenerative hub-genes (purple) were detected by comparing Signature C (darkorange) and wild-derived amyloid response (Fisher’s exact test: P = 1.62 × 10−19; Onos et al., 2019).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Onos et al., 2019 source
  • Findingown data

    In comparison to the 35-gene module from Onos et al., 19 of their genes were significantly enriched also in the darkorange module (Fisher exact test, P = 1.62 × 10−19).

    “In comparison to their 35-gene module, we found that 19 of their genes were significantly enriched also in our darkorange module (Fig. 6 C, highlighted in purple; Fisher exact test, P = 1.62 × 10−19).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Onos et al., 2019 source
  • Findingown data

    Trem2 is present in Signatures A and C.

    “For example, Trem2, a known AD risk gene expressed in microglia (Krasemann et al., 2017; Sims et al., 2017), is present in Signatures A and C.”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Krasemann et al., 2017 source
    • cites Sims et al., 2017 source
  • Classified as probably not a substantial claim. 33
  • May combine two claims. 23
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Previously, genetic background has been shown to influence the amount of tau and the presence of at least one phospho-epitope in tau transgenic models.

    “Previously, genetic background has been shown to influence the amount of tau and the presence of at least one phospho-epitope in tau transgenic models (Eskandari-Sedighi et al., 2017; Yanagisawa et al., 2021; Bailey et al., 2014).”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites Eskandari-Sedighi et al., 2017 source

      The Results section, “Genetic profiles and tau expression in sublines of TgTauP301L mice” (page unavailable), reports no significant difference in human tau expression between the three genetic backgrounds. The Background says variation in tau deposition was shared between, and independent of, those backgrounds; the Results also report AT8-negative animals in all three. This paper therefore does not show the attributed genetic-background effect on tau amount or phospho-epitope presence. (LLM, conf=0.86)

      Checked by a reasoning model — may be wrong.

      Experimental — accuracy not yet measured
    • cites Yanagisawa et al., 2021 source
    • cites Bailey et al., 2014 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Onos and colleagues observed an increase in neuroinflammation in the cortex and hippocampus of PWK mice.

    “Notably, Onos and colleagues observed an increase in neuroinflammation in the cortex and hippocampus of PWK mice.”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Onos et al., 2019 source

      The Discussion describes substantial neuroinflammation in PWK.APP/PS1 mice, and the Results report that PWK had the greatest difference in myeloid-related gene expression between wild-type and APP/PS1 mice. The cited passages do not establish an increase specifically in both the cortex and hippocampus, and the claim omits the APP/PS1 genotype. (LLM, conf=0.87)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Seeding precedes tau pathogenesis and can even occur in brain regions where tau pathology does not usually present.

    “Several studies have shown that seeding precedes tau pathogenesis and can even occur in brain regions where tau pathology does not usually present (DeVos et al., 2018; Kaufman et al., 2018; Stopschinski et al., 2021).”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites DeVos et al., 2018 source
    • cites Kaufman et al., 2018 source
    • cites Stopschinski et al., 2021 source
  • Classified as probably not a substantial claim.

    Premisecitation

    Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner.

    “Proteopathic tau seeds are capable of entering a cell and promoting aggregation in a prion-like manner (Clavaguera et al., 2009; Frost et al., 2009).”
    Quote in the paperSubstantial claim2 of 2 sources checked
    • cites Clavaguera et al., 2009 source

      In the supplied passage labeled Abstract (page unavailable), the paper reports that insoluble tau induces aggregation and compares the spreading of tau pathology to prions. It does not establish that tau seeds enter cells: it presents entry as one possible mechanism and induction from outside cells as another. (LLM, conf=0.90)

      Experimental — accuracy not yet measured
    • cites Frost et al., 2009 source
  • May combine two claims.

    Premisecitation

    Wild-derived mouse variants include over 5 million SNPs, 116 novel genes not present in B6, and between 250 and 400 large structural variants.

    “These variants include over 5 million single nucleotide polymorphisms (SNPs; Onos et al., 2019), 116 novel genes not present in B6 (Lilue et al., 2018), and between 250 and 400 large structural variants (Yalcin et al., 2011).”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites Onos et al., 2019 source
    • cites Lilue et al., 2018 source

      The Results section, “Sequence assemblies and genome annotation” (page not available), identifies putative novel loci in wild-derived strains that do not overlap genes projected from the reference genome. It reports an average of 37 such genes per wild-derived strain, not the 116 novel genes attributed to Lilue et al. The SNP and structural-variant counts have separate citations and are not judged here. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
    • cites Yalcin et al., 2011 source

      The paper reports structural variants in four wild-derived inbred mouse strains, supporting that part of the cited clause. Its Abstract reports 0.71 million variants across all 17 strains, but our copy does not give a count of 250–400 large structural variants. The SNP and novel-gene figures have separate citations and are not assessed here. (LLM, conf=0.82)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Hyperphosphorylated tau has been shown to cause neuronal cell death in humans.

    “hyperphosphorylated tau has been shown to cause neuronal cell death (Lee et al., 2011)”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Lee et al., 2011 source

      The introductory discussion says altered tau can cause neurodegeneration and that tau hyperphosphorylation is observed in human disease. But it says the contribution of phosphorylation to the onset of tau pathology in Alzheimer’s disease remains uncertain; it does not establish that hyperphosphorylated tau causes neuronal cell death in humans. The cited review supports a link between tau changes and neurodegeneration, not the claim’s specific causal conclusion. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    CAST, PWK, and WSB mice contain millions of variants across the mouse genome.

    “CAST, PWK, and WSB mice contain millions of variants across the mouse genome (Blake et al., 2021).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Blake et al., 2021 source

      The section “Strain group comparisons for murine SNP data” (page not provided) says MGD contains almost 16 million SNPs from 88 mouse strains. It does not identify CAST, PWK, or WSB or establish that those particular strains each contain millions of variants. (LLM, conf=0.84)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Several studies have shown that transcriptional signatures can be used to investigate Aβ accumulation, region-specific expression of tau, and activated immune response.

    “Several studies have shown that this hypothesis-generating, unbiased readout can be used to investigate Aβ accumulation (Sierksma et al., 2020), region-specific expression of tau (Castanho et al., 2020), and activated immune response (Kang et al., 2018).”
    Quote in the paperNot a substantial claim3 of 3 sources checked
    • cites Sierksma et al., 2020 source
    • cites Castanho et al., 2020 source

      The Introduction and Results describe transcriptional changes associated with tau pathology in the entorhinal cortex and compare findings with the hippocampus. They support using transcriptional signatures to investigate tau-related changes across brain regions, but do not establish region-specific expression of tau itself. The Aβ and immune-response clauses are attributed to other citations, not Castanho et al. (LLM, conf=0.78)

      Experimental — accuracy not yet measured
    • cites Kang et al., 2018 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    A previous study identified 11 mouse orthologs of genes within human AD GWAS loci that were co-expressed in mouse models of amyloid deposition.

    “First, a previous study identified 11 mouse orthologs of genes within human AD genome-wide association study (GWAS) loci that were co-expressed in mouse models of amyloid deposition (Salih et al., 2019).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Salih et al., 2019 source

      The Results section describes a co-expression network in amyloid-responsive mouse microglia containing seven established AD GWAS-associated genes and four newly proposed risk genes—11 genes in total (page unavailable). But it says the four new genes had not previously been reported as significantly associated with AD by traditional GWAS, so it does not support calling all 11 genes within established human AD GWAS loci. (LLM, conf=0.88)

      Experimental — accuracy not yet measured
  • Classified as probably not a substantial claim. May combine two claims.

    Premisecitation

    Recent studies in AD have shown that mouse genetic background can modulate Aβ accumulation, immune response, and tau propagation.

    “Recent studies in AD have shown that mouse genetic background can modulate Aβ accumulation (Onos et al., 2019), immune response (Yang et al., 2021), and tau propagation (Dujardin et al., 2022).”
    Quote in the paperSubstantial claim3 of 3 sources checked
    • cites Onos et al., 2019 source
    • cites Yang et al., 2021 source
    • cites Dujardin et al., 2022 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Previous studies of Trem2 on mixed background mice indicated an allele inherited by the SJL strain that unknowingly introduced a missense mutation.

    “Previous studies of Trem2 on mixed background mice indicated an allele inherited by the SJL strain that unknowingly introduced a missense mutation (Yang et al., 2021).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Yang et al., 2021 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    The gating strategy for singlet selection, CFP background removal, and FRET+ signal (BV510 channel) was performed as previously described.

    “Our gating strategy for singlet selection, CFP background removal, and FRET+ signal (BV510 channel) were performed as previously described (Martinez et al., 2022).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Martinez et al., 2022 source
  • Classified as probably not a substantial claim.

    Premisecitation

    11 mouse genes previously reported as orthologs of genes within human AD GWAS loci were selected.

    “To characterize whether genes at known AD risk loci were responsible for the effect of genetic background, we selected 11 mouse genes previously reported as orthologs of genes within human AD GWAS loci (Salih et al., 2019).”
    Quote in the paperSubstantial claim1 of 1 sources checked
    • cites Salih et al., 2019 source

      The Results section (page unavailable) lists seven mouse genes whose human orthologues are established Alzheimer’s GWAS genes. It also describes four additional orthologues associated with Alzheimer’s disease in a gene-based analysis, but explicitly says those four had not previously been reported as significantly associated using traditional GWAS. The source therefore supports the orthologue relationship, not the characterization of all 11 as genes within previously known GWAS loci. (LLM, conf=0.86)

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Premisecitation

    Seeding activity has been shown to identify the action of high molecular weight tau and to differentiate between specific conformers in 3R/4R tau diseases.

    “As a pathological readout, seeding activity has been shown to identify the action of high molecular weight tau (Martinez et al., 2022) and even differentiate between specific conformers in 3R/4R tau diseases (Kraus et al., 2019).”
    Quote in the paperNot a substantial claim2 of 2 sources checked
    • cites Martinez et al., 2022 source
    • cites Kraus et al., 2019 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductcitation

    In previous studies, mice homozygous for the SJL allele were excluded from analysis.

    “In previous studies, we have addressed this issue by excluding mice that are homozygous for the SJL allele from analysis (Karahan et al., 2021).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Karahan et al., 2021 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Onos and colleagues reported a list of 35 genes associated with a wild-derived specific response to amyloid transgene, identified as the 'light yellow' module via WGCNA module-trait analyses for genetic background and presence of the APP/PS1 transgene.

    “First, Onos and colleagues reported a list of genes associated with a wild-derived specific response to amyloid transgene (Onos et al., 2019). This list of 35 genes was identified as the “light yellow” module via WGCNA module–trait analyses for genetic background and presence of the APP/PS1 transgene (Onos et al., 2019).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Onos et al., 2019 source

      Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

      Experimental — accuracy not yet measured
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Previous research has demonstrated that interactors like Bassoon (Bsn) contribute to the ability of tau to seed and induce neurotoxicity.

    “Our previous research has demonstrated that interactors like Bassoon (Bsn) contribute to the ability of tau to seed and induce neurotoxicity (Martinez et al., 2022).”
    Quote in the paperNot a substantial claim1 of 1 sources checked
    • cites Martinez et al., 2022 source
  • May combine two claims.

    Findingown data

    Consistent tau expression was observed in the cortex of AAV-hTauP301L-injected mice but not in AAV-eGFP-injected mice.

    “Consistent tau expression was observed in the cortex of AAV-hTauP301L–injected mice (Fig. S2 A) but not in AAV-eGFP–injected mice (Fig. S2 B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    2,601 out of 5,792 variant calls were identical across CAST, PWK, and WSB mice, and there were strain-specific variants.

    “While a large portion of these variant calls was identical across CAST, PWK, and WSB mice (2,601 out of 5,792), there were a number of strain-specific variants.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The darkorange module is the only one of these four modules to be positively correlated to FRET measurement (R2 = 0.54, P = 7 × 10−6) and showed a positive correlation to wild-derived background (R2 = 0.27, P = 0.03).

    “The darkorange module is the only one of these four modules of interest to be positively correlated to FRET measurement (Fig. 5 A, R2 = 0.54, P = 7 × 10−6) and showed a positive correlation to wild-derived background (R2 = 0.27, P = 0.03).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    A total of 4,784 DEGs were identified in B6; 5,260 in CAST; 4,657 in PWK; and 4,958 in WSB.

    “We identified a total of 4,784 DEGs in B6; 5,260 DEGs in CAST; 4,657 DEGs in PWK, and 4,958 DEGs in WSB (DEG set size, Fig. 3 C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Cyp3a43 contained the most genotyped variants with 563, only 163 of which were shared among all wild-derived mice.

    “Cytochrome P450 3A43 (Cyp3a43; chr5: 137890932–146113285) contained the most genotyped variants with 563, only 163 of which were shared among all wild-derived mice.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    Within Inpp5d, there were five genotyped variants: one SNP shared by all three wild-derived mice, three SNPs shared only by CAST and PWK, and one SNP heterozygous in CAST and PWK but homozygous in WSB.

    “within inositol polyphosphate-5-phosphatase D (Inpp5d;chr1:87620312–87720507), there were five genotyped variants (Fig. 1 B). One SNP was shared between all three wild-derived mice, three SNPs were shared only by CAST and PWK, and one SNP was heterozygous in CAST and PWK but homozygous in WSB (Table S1 C).”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Findingown data

    There are 53 CAST-specific DEGs, 22 PWK-specific DEGs, and 25 WSB-specific DEGs.

    “There are 53 CAST-specific DEGs, 22 PWK-specific DEGs, and 25 WSB-specific DEGs.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    Signatures A-C represent a core response to expressing AAV-hTauP301L (Signature A), a wild-derived specific response to AAV-hTauP301L expression (Signature B), and a tau seeding-associated module (Signature C).

    “Signatures A–C of this study represent a core response to expressing AAV-hTauP301L (Signature A), wild-derived specific response to AAV-hTauP301L expression (Signature B), and a tau seeding–associated module (Signature C).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The homeostatic microglial signature was significantly enriched (Fisher's exact test: P = 2.44 × 10−7) and showed the largest decrease in PWK mice injected with AAV-hTauP301L.

    “The homeostatic microglial signature was significantly enriched (Fisher’s exact test: P = 2.44 × 10−7) and showed the largest decrease in PWK injected with AAV-hTauP301L.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The disease-associated microglial signature was significantly enriched (Fisher's exact test: P = 2.31 × 10−5) and shows the largest increase in PWK mice injected with AAV-hTauP301L.

    “The disease-associated microglial signature was significantly enriched (Fisher’s exact test: P = 2.31 × 10−5) and shows the largest increase in PWK injected with AAV-hTauP301L.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    The eigenvalue of genes in the darkorange module follows a similar pattern to tau seeding findings, with CAST and PWK mice showing increased expression relative to B6 and WSB.

    “Furthermore, the eigenvalue of genes in this module follows a similar pattern to the tau seeding findings, with CAST and PWK mice showing increased expression relative to B6 and WSB.”
    • Also stated in: § Signature C: Darkorange module implicates microglia in response to tau seeds · plain
      “Differences observed in eigengene expression follow a similar pattern to tau seeding activity, with the largest increases observed in CAST and PWK mice injected with AAV-hTauP301L.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Findingown data

    We determined strain-specific genetic variants in wild-derived mouse genetic background using the Illumina Infinium platform and reported three transcriptional signatures identified via RNA-seq.

    “In conclusion, we determined strain-specific genetic variants in wild-derived mouse genetic background using Illumina Infinium platform and reported three transcriptional signatures identified via RNA-seq.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Findingown data

    WGCNA identified a total of 60 modules.

    “A total of 60 modules were identified (Fig. S4 C)”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing). May combine two claims.

    Findingown data

    Using the marker selection approach, 170 DAM markers and 175 homeostatic markers were identified.

    “Using this approach, we identified 170 DAM markers and 175 homeostatic markers.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    Hyperphosphorylated tau correlates with measures of cognitive decline in humans.

    “to correlate with measures of cognitive decline (Arriagada et al., 1992) in humans.”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Arriagada et al., 1992 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Interpretationnone given

    The significantly enriched KEGG pathways in Signature B, such as asthma and Staphylococcus aureus infection, are not obviously associated with the study of tauopathy.

    “The significantly enriched KEGG pathways, such as asthma (KEGG:05310) and Staphylococcus aureus infection (KEGG:05150), are not obviously associated with the study of tauopathy.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Interpretationreasoning

    Trem2 is responsive to tau across mouse strains and is correlated to tau seeding observed in wild-derived mice.

    “From this, we could conclude that Trem2 is responsive to tau across mouse strains and is correlated to tau seeding observed in wild-derived mice (Fig. 9 B).”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    The targeted transcriptomic approach identified two microglial pathways and replicated the bulk RNA-seq transcriptomics findings.

    “In summary, these analyses of the targeted transcriptomic approach identified two microglial pathways and replicated our findings from bulk RNA-seq transcriptomics data.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationreasoning

    Trem2 response to tau is resilient to changes in genetic background and contributes to the formation of tau seeds.

    “This suggests that Trem2 response to tau is resilient to changes in genetic background and contributes to the formation of tau seeds.”
    Quote in the paperSubstantial claim
  • May combine two claims.

    Interpretationown data

    Network analysis implicated microglia in the strain-specific seeding activity and replicated the findings using a targeted neuroinflammation panel.

    “To better understand the mechanisms involved, we performed a network analysis that implicated microglia in this strain-specific seeding activity and replicated our findings using a targeted neuroinflammation panel.”
    Quote in the paperSubstantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    These wild-derived strains are an ideal resource for investigating the contribution of genetic variation to the study of AD and other tauopathies.

    “Our data suggest that these wild-derived strains are an ideal resource for investigating the contribution of genetic variation to the study of AD and other tauopathies.”
    Quote in the paperNot a substantial claim
  • May combine two claims.

    Premisecitation

    AAV9 has been shown to have high intracellular expression without an effect on mouse genetic background.

    “We selected AAV9, which has been shown to have high intracellular expression without an effect on mouse genetic background (He et al., 2019).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites He et al., 2019

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    After outlier removal in WGCNA, 60 samples remained.

    “After outlier removal in WGCNA, we were left with a total of 60 samples (Fig. S4 A).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    Including wild-derived mice may enhance the translatability to treating patients with different genetic backgrounds.

    “Given that most therapeutic approaches are tested in mice before progressing to clinical trials, including wild-derived mice may enhance the translatability to treating patients with different genetic backgrounds.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    The final sample size reached our requirement based on power analysis (B6 = 20, CAST = 20, PWK = 19, WSB = 24).

    “The final sample size reached our requirement based on power analysis (B6 = 20, CAST = 20, PWK = 19, WSB = 24).”
    Quote in the paperSubstantial claim
  • Classified as probably not a substantial claim.

    Study design and conductown data

    A targeted assay (Nanostring Neuroinflammation Panel) was selected to independently validate the module discovered via network analysis of whole transcriptomic data.

    “To independently validate the module discovered via network analysis of whole transcriptomic data (Figs. 5 and 6), we selected a targeted assay (Nanostring Neuroinflammation Panel) that provides a comprehensive survey of neuroinflammation (Fig. 7).”
    Quote in the paperSubstantial claim
    • Rests on an assumption: The Nanostring Neuroinflammation Panel provides a comprehensive survey of neuroinflammation.
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Premisecitation

    The gigaMUGA array contains 143,259 SNP and copy number variant markers that were selected to be informative in wild-derived mice and multiple Mus species.

    “This array contains 143,259 SNP and copy number variants markers that were selected to be informative in wild-derived mice and multiple Mus species (Morgan et al., 2015).”
    Quote in the paperNot a substantial claim0 of 1 sources checked
    • cites Morgan et al., 2015

      Couldn’t be matched to a paper in Crossref, so it can’t be checked.

  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Sample size was determined by the pilot study described in the Results section.

    “Sample size was determined by the pilot study described in the Results section.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    Total brain lysate was transfected without normalizing to total tau levels.

    “Total brain lysate was transfected without normalizing to total tau levels.”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductown data

    The data did not reach the suggested scale-free topology model fit cutoff of 0.9.

    “Our data did not reach the suggested scale-free topology model fit cutoff of 0.9 (Fig. S4 B).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationown data

    Our data provide a resource for investigating tau in mouse models of AD and other tauopathies.

    “Our data provide a resource for investigating tau in mouse models of AD and other tauopathies (Fig. 9 and Fig. S5).”
    Quote in the paperNot a substantial claim
  • Probably not a substantial claim: may not pass S2 (checkable).

    Interpretationreasoning

    The differential susceptibility of PWK and CAST mice to tauopathy implicates them as promising founder strains in future genetic mapping studies.

    “Additionally, this differential susceptibility of PWK and CAST mice to tauopathy implicates them as promising founder strains in future genetic mapping studies.”
    Quote in the paperNot a substantial claim
  • Classified as probably not a substantial claim.

    Premisecitation

    The seeding assay was performed using TauRD P301S FRET Biosensor Cells.

    “The seeding assay was performed using TauRD P301S FRET Biosensor Cells (Holmes et al., 2014).”
    Quote in the paperSubstantial claim0 of 1 sources checked
    • cites Holmes et al., 2014 source
  • Probably not a substantial claim: may not pass S3 (load-bearing).

    Study design and conductnone given

    All procedures and animal work were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee (Protocol 21149).

    “All procedures and animal work were approved by the Indiana University School of Medicine Institutional Animal Care and Use Committee (Protocol 21149).”
    Quote in the paperNot a substantial claim
51 of 51
  • The authors state this as an assumption.

    FRET+ signal in the tau biosensor assay is a valid proxy for tau seeding activity.

    “FRET+ signal is then measured by fluorescence-activated cell sorting (FACS) as a proxy for tau seeding activity.”
  • The paper relies on this without support.

    Most studies use the same monogenic mouse models, unlike genetically diverse human patients.

    “Unlike human patients who are genetically diverse, most studies use the same monogenic mouse models.”
  • The paper relies on this without support.

    The AMP-AD nominated target genes are relevant to AD and related dementias.

    “we focused on target genes nominated by the AMP-AD consortium.”
  • The paper relies on this without support.

    No transcriptional information or mechanism of action has ever been proposed for how genetic background influences tau.

    “However, no transcriptional information or mechanism of action has ever been proposed.”
  • The paper relies on this without support.

    The Nanostring Neuroinflammation Panel provides a comprehensive survey of neuroinflammation.

    “we selected a targeted assay (Nanostring Neuroinflammation Panel) that provides a comprehensive survey of neuroinflammation (Fig. 7).”
5 of 5

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

Each contradiction between two passages listed here was confirmed by an independent check.

  • CAST seeding comparison is described as P < 0.001 despite an adjusted P of 0.046

    Major

    The reported adjusted P value for B6 versus CAST is 0.046, contradicting the claim that both CAST and PWK differ from B6 at P < 0.001. CAST remains significant at the 0.05 threshold, but not at the stated threshold.

  • Main seeding-assay incubation is reported as both 24 and 48 hours

    Minor

    Figure 2 describes transfecting biosensor cells with brain lysate for 24 hours, whereas the seeding-assay method says cells were harvested after an additional 48 hours.

  • Variant totals differ between Figure 1 and the Results

    Minor

    The figure legend reports 5,810 variants in the 537 target genes, while the Results report 5,792 for the same target-gene set.

  • Homeostatic microglial enrichment has two reported P values

    Minor

    The Figure 6 legend and Results give different P values for the homeostatic microglial marker enrichment.

4 of 4

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Acri, D. J., You, Y., Tate, M. D., Karahan, H., Martinez, P., McCord, B., Sharify, A. D., John, S., Kim, B., Dabin, L. C., Philtjens, S., Wijeratne, H. R. S., McCray, T. J., Smith, D. C., Bissel, S. J., Lamb, B. T., Lasagna-Reeves, C. A., & Kim, J.
Affiliations
  • Indiana University Indianapolis (US)
  • Indiana University 3 Department of Anatomy, Cell Biology and Physiology, , Indianapolis, IN, USA
  • Stark Neurosciences Research Institute, Indiana University 1 , Indianapolis, IN, USA
Corresponding author
Kim, Jungsu
Venue
Journal of Experimental Medicine
Published
2023-08-22
Volume
220
Issue
11
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
OpenAlex
W4386045870
Cited by
3
References
82
Citations by year
2026: 2 · 2024: 1
FWCI
0.43
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion, cc-by)
  • bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
  • PubMed (publishedVersion)
  • IUScholarWorks (Indiana University) (submittedVersion, cc-by)
  • PubMed Central (submittedVersion, cc-by)
  • PubMed Central (submittedVersion)
Funders
  • National Institutes of Health (R01 AG077829, R01 AG071281, RF1 AG074543, R21 AG072738, T32AG071444, F31AG074673, F30AG079580, F31AG074628, T32DK064466)
  • Indiana University
  • School of Medicine, Indiana University
  • Indiana Clinical Translational Sciences Institute
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
tau aggregation, tau seeding, Alzheimer's disease, genetic background, wild-derived mice, MAPT, transcriptome, microglia, gene modules, CAST/EiJ, C57BL/6J mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Claims read by deepseek-v4.1-flash under definition version 3 (extract-v3) on 2026-10-17.

Classified by jev-1.13-20260917 (gold-guideline-v0.2) on 2026-10-17.

Cited sources are checked by gpt-6-sol.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review